May 4, 2017 / 10:55 AM / 3 months ago

BRIEF-Epizyme Earns $10 million milestone payment from Glaxosmithkline

1 Min Read

May 4 (Reuters) - Epizyme Inc:

* Epizyme earns $10 million milestone payment from glaxosmithkline for initiation of GLP Toxicology studies with novel methyltransferase inhibitor

* Epizyme - milestone payment follows GSK'S initiation of GLP toxicology studies for methyltransferase inhibitor discovered by co, licensed to GSK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below